Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. News
  7. Summary
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Swedish Orphan Biovitrum : EU, Turkey Green-light Advent, GIC's Sobi Acquisition

10/08/2021 | 06:02am EST


ę MT Newswires 2021
All news about SWEDISH ORPHAN BIOVITRUM AB (PUBL)
12/01Selecta Biosciences, Swedish Orphan Biovitrum Complete Enrollment in Phase 3 SEL-212 St..
MT
12/01Swedish Orphan Biovitrum, Selecta Biosciences Complete Enrolment In Gout Treatment Stud..
MT
12/01Sobi and Selecta Biosciences announce completion of enrolment in DISSOLVE Phase 3 study..
AQ
11/23Advent, GIC Agree Final Extension of Acceptance Period in Sobi Takeover
MT
11/16Advent, GIC Waive Conditions on Sobi Takeover, Acceptance Period Extended Anew
MT
11/08Advent, GIC Further Extend Acceptance Period for Sobi Takeover
MT
11/04Sobi to present new data at the ASH 2021 Annual Meeting
AQ
10/25SWEDISH ORPHAN BIOVITRUM : Sobi publishes report for the third quarter 2021
AQ
10/25SWEDISH ORPHAN BIOVITRUM : Advent, GIC Extend Acceptance Period for Sobi Takeover
MT
10/22SWEDISH ORPHAN BIOVITRUM : Sobi publishes report for the third quarter 2021
AQ
More news
Analyst Recommendations on SWEDISH ORPHAN BIOVITRUM AB (PUBL)
More recommendations
Financials
Sales 2021 15 023 M 1 655 M 1 655 M
Net income 2021 2 252 M 248 M 248 M
Net Debt 2021 10 197 M 1 124 M 1 124 M
P/E ratio 2021 29,7x
Yield 2021 -
Capitalization 66 703 M 7 384 M 7 350 M
EV / Sales 2021 5,12x
EV / Sales 2022 4,54x
Nbr of Employees 1 532
Free-Float 59,5%
Chart SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Duration : Period :
Swedish Orphan Biovitrum AB (publ) Technical Analysis Chart | SOBI | SE0000872095 | MarketScreener
Technical analysis trends SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 226,00 SEK
Average target price 212,29 SEK
Spread / Average Target -6,07%
EPS Revisions
Managers and Directors
Guido Oelkers President & Chief Executive Officer
Henrik Stenqvist Chief Financial Officer
Sven Hňkan Bj÷rklund Chairman
Anne Marie de Jonge Schuermans Head-Technical Operations
Ravi Madduri Rao Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
SWEDISH ORPHAN BIOVITRUM AB (PUBL)36.06%7 384
CSL LIMITED9.18%99 188
WUXI BIOLOGICS (CAYMAN) INC.4.77%57 826
SAMSUNG BIOLOGICS CO.,LTD.7.87%49 556
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-6.27%34 628